“`html
On October 24, 2023, Johnson & Johnson (JNJ) reported a trading volume of 39,084 contracts, equating to approximately 3.9 million underlying shares, which is 45.8% of its average daily trading volume of 8.5 million shares over the past month. The $207.50 strike call option expiring on November 21, 2025, saw particularly high activity with 11,319 contracts traded, representing about 1.1 million underlying shares.
Moderna Inc. (MRNA) also experienced notable trading, with 55,785 contracts exchanged, translating to around 5.6 million underlying shares, or 45.5% of its average daily volume of 12.3 million shares. Specifically, the $25 strike call option set to expire on November 28, 2025, had high trading with 6,094 contracts, equivalent to approximately 609,400 underlying shares.
Albemarle Corp. (ALB) reported trading of 18,359 contracts today, representing about 1.8 million underlying shares, which is 45.1% of its monthly average of 4.1 million shares. The $60 strike put option expiring on December 19, 2025, saw significant trading activity with 10,000 contracts traded, around 1.0 million underlying shares.
“`
